ARROWHEAD PHARMACEUTICALS IN (ARWR)

US04280A1007 - Common Stock

23.61  +1.31 (+5.87%)

After market: 23.5 -0.11 (-0.47%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ARROWHEAD PHARMACEUTICALS IN

NASDAQ:ARWR (12/6/2024, 8:00:00 PM)

After market: 23.5 -0.11 (-0.47%)

23.61

+1.31 (+5.87%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-1.25%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap2.94B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
Short Float %
Short Ratio
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ARWR Daily chart

Company Profile

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The company is headquartered in Pasadena, California and currently employs 525 full-time employees. The firm's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The firm's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The company is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. The company has around 14 clinical-stage investigational medicines (nine wholly owned and five partnered), which range in development stage from Phase I to Phase III. The firm's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MUC5AC, ARO-MMP7, GSK-4532990, Fazirsiran, JNJ-3989, HZN-457, ARO-C3, ARO-PNPLA3, ARO-DUX4 and ARO-SOD1.

Company Info

ARROWHEAD PHARMACEUTICALS IN

177 E Colorado Blvd, Suite 700

Pasadena CALIFORNIA 91105

P: 16266964702

CEO: Christopher Anzalone

Employees: 525

Website: https://arrowheadpharma.com/

ARWR News

News Image5 days ago - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
News Image6 days ago - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals to Participate in Upcoming December 2024 Conferences
News Image10 days ago - Market News VideoNoteworthy Wednesday Option Activity: ARWR, MARA, KSS
News Image11 days ago - Market News VideoARWR Crosses Above Key Moving Average Level
News Image11 days ago - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
ChartMill News Image12 days ago - ChartmillThe market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

ARWR Twits

Here you can normally see the latest stock twits on ARWR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example